City Therapeutics, Inc. (CTY): who owns it and who trades it
As of Nov 10, 2026, CTY insiders reported 1 purchase worth $3.1M in the last 12 months. The largest buyer was ARCH Venture Partners XII, LLC (10% owner), with $3.1M.
Latest filing Nov 10, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, CTY insiders reported $3.1M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | ARCH Venture Partners XII, LLC +5 | 10% owner | Purchase | 170,000 | $18.00 | $3.1M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ARCH Venture Partners XII, LLC | 10% owner | $3.1M | – | Oct 19, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CTY short interest
822,840 CTY shares are sold short.
As of Oct 30, 2026, 822,840 CTY shares were sold short. At the average daily volume of 361,905 shares, buying them all back would take about 2.3 trading days (days to cover).
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 822,840 | – | – | 361,905 | 2.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
City Therapeutics company events
City Therapeutics filed 2 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 10, 2026.
- Nov 10, 2026AnnouncementShared information with investors. Filing
- Oct 19, 2026RulesChanged its bylaws or articles. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named CTY in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 6, 2026 | FMR LLC | 13G | 14.0% |
| Nov 6, 2026 | FMR LLC | 13G | 14.0% |
| Oct 26, 2026 | ARCH Venture Fund XII, L.P. | 13D | 25.6% |
| Oct 26, 2026 | ARCH Venture Fund XII, L.P. | 13D | 25.6% |
| Oct 26, 2026 | VIKING GLOBAL INVESTORS LP | 13G | 7.0% |
| Oct 26, 2026 | VIKING GLOBAL INVESTORS LP | 13G | 7.0% |
| Oct 22, 2026 | Invus Public Equities, L.P. | 13G | 8.1% |
| Oct 22, 2026 | Invus Public Equities, L.P. | 13G | 8.1% |
Questions about City Therapeutics, Inc. (CTY) stock
Are CTY insiders buying or selling?
In the last 12 months, CTY insiders reported 1 open-market purchase worth $3.1M and no sales. The latest trade was on Oct 19, 2026. See every trade.
What is the short interest in CTY?
As of Oct 30, 2026, 822,840 CTY shares were sold short. At the average daily volume of 361,905 shares, buying them all back would take about 2.3 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.